日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

在预后不良的老年体格健壮急性髓系白血病患者中,采用阿扎胞苷和来那度胺交替维持治疗:一项 II 期多中心 FILO 试验

Hunault-Berger, M; Maillard, N; Himberlin, C; Recher, C; Schmidt-Tanguy, A; Choufi, B; Bonmati, C; Carré, M; Couturier, M-A; Daguindau, E; Marolleau, J-P; Orsini-Piocelle, F; Delaunay, J; Tavernier, E; Lissandre, S; Ojeda-Uribe, M; Sanhes, L; Sutton, L; Banos, A; Fornecker, L M; Bernard, M; Bouscary, D; Saad, A; Puyade, M; Rouillé, V; Luquet, I; Béné, M C; Hamel, J-F; Dreyfus, F; Ifrah, N; Pigneux, A

Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)

在接受来那度胺治疗的低危骨髓增生异常综合征伴del(5q)患者中验证IPSS-R

Sekeres, M A; Swern, A S; Fenaux, P; Greenberg, P L; Sanz, G F; Bennett, J M; Dreyfus, F; List, A F; Li, J S; Sugrue, M M

Thrombopoietin stimulates cortactin translocation to the cytoskeleton independently of tyrosine phosphorylation.

血小板生成素刺激皮质肌动蛋白向细胞骨架的转位,而与酪氨酸磷酸化无关

Lopez I, Duprez V, Melle J, Dreyfus F, Lévy-Tolédano S, Fontenay-Roupie M